Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-2.01
↑ 79% vs avg
Percentile
P100
Near historical high
Streak
5 yr
Consecutive growthElevated
Average
-9.63
Historical baseline
PeriodValueYoY Change
2024-2.01+35.8%
2023-3.12+8.4%
2022-3.41+32.1%
2021-5.02+29.1%
2020-7.07+79.5%
2019-34.55-182.9%
2018-12.21-